Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Martin Pulé(Houston Methodist), Barbara Savoldo(Methodist Hospital), Gary D. Myers(Texas Children's Hospital), Claudia Rössig(Methodist Hospital), Heidi V. Russell(Texas Children's Hospital), Gianpietro Dotti(Houston Methodist), M. Helen Huls(Texas Children's Hospital), Enli Liu(Houston Methodist), Adrian P. Gee(Texas Children's Hospital), Zhuyong Mei(Baylor College of Medicine), Éric Yvon(Houston Methodist), Heidi L. Weiss(Baylor College of Medicine), Hao Liu(Children's Cancer Center), Cliona M. Rooney(Baylor College of Medicine), Helen E. Heslop(Texas Children's Hospital), Malcolm K. Brenner(Methodist Hospital)
Nature Medicine
November 1, 2008
10.1038/nm.1882
Cited by 1,186Open Access
Full Text

Abstract

Related Papers

Epstein–Barr virus: 40 years on
Lawrence S. Young, Alan B. Rickinson|Nature reviews. Cancer|2004|2.2k
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Weiping Zou|Nature reviews. Cancer|2005|2k
Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients
Cliona M. Rooney, Colton A. Smith, Catherine Y. Ng et al.|Blood|1998|1.1k
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
Mark J. Smyth, Gavin P. Dunn, Robert D. Schreiber|Advances in immunology|2006|855
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger, Michael C. Jensen, Peter M. Lansdorp et al.|Journal of Clinical Investigation|2008|832